P

Inventor

THOMPSON SCOTT K

US48 patents
⚠️ This page may combine multiple inventors who share the name “THOMPSON SCOTT K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ASANA BIOSCIENCES LLC

19 patents
US9944637B2Apr 17, 2018

P2X3 and/or P2X2/3 compounds and methods

ASANA BIOSCIENCES LLC5 citations82
US9908879B2Mar 6, 2018

P2X3 and/or P2X2/3 compounds and methods

ASANA BIOSCIENCES LLC5 citations82
US10174039B2Jan 8, 2019

P2X3 and/or P2X2/3 compounds and methods

ASANA BIOSCIENCES LLC4 citations81
US9499495B2Nov 22, 2016

Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways

ASANA BIOSCIENCES LLC4 citations80
US11103491B2Aug 31, 2021

Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer

ASANA BIOSCIENCES LLC2 citations71
US10751332B2Aug 25, 2020

Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer

ASANA BIOSCIENCES LLC2 citations71
US10590127B2Mar 17, 2020

P2X3 and/or P2X2/3 compounds and methods

ASANA BIOSCIENCES LLC1 citations71
US10544145B2Jan 28, 2020

P2X3 and/or P2X2/3 compounds and methods

ASANA BIOSCIENCES LLC1 citations71
US10316039B2Jun 11, 2019

P2X3 and/or P2X2/3 compounds and methods

ASANA BIOSCIENCES LLC2 citations71
US11339169B2May 24, 2022

P2X3 and/or P2X2/3 compounds and methods

ASANA BIOSCIENCES LLC2 citations70
US10611768B2Apr 7, 2020

P2X3 and/or P2X2/3 compounds and methods

ASANA BIOSCIENCES LLC2 citations70
US10471051B2Nov 12, 2019

Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer

ASANA BIOSCIENCES LLC3 citations70
US9896445B2Feb 20, 2018

Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer

ASANA BIOSCIENCES LLC3 citations70
US11685736B2Jun 27, 2023

P2X3 and/or P2X2/3 compounds and methods

ASANA BIOSCIENCES LLC0 citations61
US12077543B2Sep 3, 2024

P2X3 and/or P2X2/3 compounds and methods

ASANA BIOSCIENCES LLC0 citations60
US11925629B2Mar 12, 2024

Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer

ASANA BIOSCIENCES LLC0 citations60
US10912779B2Feb 9, 2021

Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways

ASANA BIOSCIENCES LLC0 citations59
US9757382B2Sep 12, 2017

Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways

ASANA BIOSCIENCES LLC0 citations48
US10226468B2Mar 12, 2019

Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways

ASANA BIOSCIENCES LLC0 citations47

TREE DEFENDER LLC

9 patents

SMITHKLINE BEECHAM CORP

6 patents

LORD CORP

5 patents

APROTECH POWERTRAIN LLC

2 patents

CURADEV PHARMA PRIVATE LTD

2 patents

SMITHKLINE CORP

1 patent

KUBAT TIMOTHY J

1 patent

OLSEN KIRK W

1 patent

BACHMEYER PAUL J

1 patent

RADICAL AG TECH INC

1 patent